These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 36061383)

  • 1. Anakinra treatment in multisystemic inflammatory syndrome in children (MIS-C) associated with COVID-19.
    Çaǧlayan Ş; Sönmez HE; Otar Yener G; Baǧlan E; Öztürk K; Ulu K; Guliyeva V; Demirkol D; Çakan M; Özdel S; Bukulmez H; Aktay Ayaz N; Sözeri B
    Front Pediatr; 2022; 10():942455. PubMed ID: 36061383
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subcutaneous anakinra in the management of refractory MIS-C in France.
    Dusser P; Belot A; Bajolle F; Kevorkian-Verguet C; Meinzer U; Huet F; Tiriau S; Kone-Paut I
    Front Pediatr; 2024; 12():1270878. PubMed ID: 38464895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical outcomes and safety of anakinra in the treatment of multisystem inflammatory syndrome in children: a single center observational study.
    Dizon BLP; Redmond C; Gotschlich EC; Sule S; Ronis T; Vazzana KM; Sherman MA; Connor R; Bosk A; Dham N; Harahsheh AS; Wells E; DeBiasi R; Srinivasalu H
    Pediatr Rheumatol Online J; 2023 Jul; 21(1):76. PubMed ID: 37525200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcomes of MIS-C patients treated with anakinra: a retrospective multicenter national study.
    Licciardi F; Covizzi C; Dellepiane M; Olivini N; Mastrolia MV; Lo Vecchio A; Monno V; Tardi M; Mauro A; Alessio M; Filocamo G; Cattalini M; Taddio A; Caorsi R; Marseglia GL; La Torre F; Campana A; Simonini G; Ravelli A; Montin D
    Front Pediatr; 2023; 11():1137051. PubMed ID: 37675397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multisystem Inflammatory Syndrome in Children (MIS-C) Associated with COVID-19: A Case Series Experience in a Tertiary Care Hospital of Southern Turkey.
    Tolunay O; Çelik Ü; Arslan İ; Orgun A; Demir H; Demir O; Dağdelen EÇ
    J Trop Pediatr; 2021 May; 67(2):. PubMed ID: 34028528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of anakinra use on clinical outcomes in children with moderate or severe multisystem inflammatory syndrome in children: a propensity score matched retrospective cohort study.
    Akkoyun EB; Most Z; Katragadda H; Yu A; Nassi L; Oakman N; Ginsburg S; Maamari M
    Pediatr Rheumatol Online J; 2023 Nov; 21(1):141. PubMed ID: 37996856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial.
    RECOVERY Collaborative Group
    Lancet Child Adolesc Health; 2024 Mar; 8(3):190-200. PubMed ID: 38272046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The clinical course and short-term health outcomes of multisystem inflammatory syndrome in children in the single pediatric rheumatology center.
    Sözeri B; Çağlayan Ş; Atasayan V; Ulu K; Coşkuner T; Pelin Akbay Ö; Hasbal Akkuş C; Atay G; Salı E; Karacan M; Öner T; Erdoğan S; Demir F
    Postgrad Med; 2021 Nov; 133(8):994-1000. PubMed ID: 34605352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of sildenafil and high-dose anakinra in an MIS-C patient with pulmonary vasculitis: A case report.
    La Torre F; Calabrese G; Signorile K; Bizzoco F; Mastrorilli C; Strippoli A; Amato D; Carella F; Vairo U; Giordano P; Milella L; Cardinale F
    Front Pediatr; 2022; 10():1015617. PubMed ID: 36644405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Variation in Early Anakinra Use and Short-Term Outcomes in Multisystem Inflammatory Syndrome in Children.
    Chang JC; Young CC; Muscal E; Sexson Tejtel SK; Newhams MM; Kucukak S; Crandall H; Maddux AB; Rowan CM; Halasa NB; Harvey HA; Hobbs CV; Hall MW; Kong M; Aguiar CL; Schuster JE; Fitzgerald JC; Singh AR; Wellnitz K; Nofziger RA; Cvijanovich NZ; Mack EH; Schwarz AJ; Heidemann SM; Newburger JW; Zambrano LD; Campbell AP; Patel MM; Randolph AG; Son MBF;
    Arthritis Rheumatol; 2023 Aug; 75(8):1466-1476. PubMed ID: 36908050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and efficacy of pharmacological approaches available for multisystem inflammatory syndrome in children (MIS-C): a systematic review.
    Velusamy Y; Vivekanandan G; Romli MH; Shankar A; Karuppiah T; Yubbu P
    Turk J Pediatr; 2023; 65(5):719-738. PubMed ID: 37853964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multisystemic inflammatory syndrome in children associated with COVID-19: a single center experience in Turkey.
    Başar EZ; Sönmez HE; Öncel S; Yetimakman AF; Babaoğlu K
    Turk Arch Pediatr; 2021; 56(3):192-199. PubMed ID: 34104908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of Intravenous Anakinra for Management of Pediatric Cytokine Storm Syndromes at an Academic Medical Center.
    Yang L; Lowry S; Heath T
    Hosp Pharm; 2023 Aug; 58(4):376-381. PubMed ID: 37360202
    [No Abstract]   [Full Text] [Related]  

  • 14. Early anakinra treatment improves cardiac outcome of multisystem inflammatory syndrome in children, regardless of disease severity.
    Taddio A; Della Paolera S; Abbagnato L; Agrusti A; Badolato R; Biscaro F; Caorsi R; Consolaro A; Dellepiane RM; Fabi M; Floretta I; Gattorno M; Giangreco M; La Torre F; Maggio MC; Mambelli L; Mauro A; Mastrolia MV; Meneghel A; Montin D; Ricci F; Simonini G; Smarrazzo A; Sottile R; Stucchi S; Tardi M; Verdoni L; Zuccotti G; Zunica F; Ravelli A; Cattalini M;
    Rheumatology (Oxford); 2024 Feb; 63(2):366-375. PubMed ID: 37647645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of early Anakinra on cardiac function in children with multisystem inflammatory syndrome of COVID-19: a systematic review.
    Shabil M; Khatib MN; Banda GT; Zahiruddin QS; Ballal S; Bansal P; Srivastava M; Arora I; Kumar MR; Sinha A; Pant K; Al-Jishi JM; Albayat H; Al Fares MA; Garout M; Alrasheed HA; Al-Subaie MF; Rabaan AA
    BMC Infect Dis; 2024 Aug; 24(1):847. PubMed ID: 39169304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prolonged Hospitalization in a Pediatric Patient With Multisystem Inflammatory Syndrome (MIS-C) and Human Rhino-Enterovirus Infection: A Case Report.
    Lee ASE; Stojkic I; Ogbu EA
    Cureus; 2022 Sep; 14(9):e29380. PubMed ID: 36304349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early combination therapy with immunoglobulin and steroids is associated with shorter ICU length of stay in Multisystem Inflammatory Syndrome in Children (MIS-C) associated with COVID-19: A retrospective cohort analysis from 28 U.S. Hospitals.
    Harthan AA; Nadiger M; McGarvey JS; Hanson K; Gharpure VP; Bjornstad EC; Chiotos K; Miller AS; Reikoff RA; Gajic O; Kumar V; Walkey AJ; Kashyap R; Tripathi S;
    Pharmacotherapy; 2022 Jul; 42(7):529-539. PubMed ID: 35661394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin-1 blockade with high-dose anakinra in patients with COVID-19, acute respiratory distress syndrome, and hyperinflammation: a retrospective cohort study.
    Cavalli G; De Luca G; Campochiaro C; Della-Torre E; Ripa M; Canetti D; Oltolini C; Castiglioni B; Tassan Din C; Boffini N; Tomelleri A; Farina N; Ruggeri A; Rovere-Querini P; Di Lucca G; Martinenghi S; Scotti R; Tresoldi M; Ciceri F; Landoni G; Zangrillo A; Scarpellini P; Dagna L
    Lancet Rheumatol; 2020 Jun; 2(6):e325-e331. PubMed ID: 32501454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Case Report: Use of Anakinra in Multisystem Inflammatory Syndrome During COVID-19 Pandemic.
    Della Paolera S; Valencic E; Piscianz E; Moressa V; Tommasini A; Sagredini R; Kiren V; Comar M; Taddio A
    Front Pediatr; 2020; 8():624248. PubMed ID: 33708752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical characteristics of children with MIS-C fulfilling classification criteria for macrophage activation syndrome.
    Buda P; Strauss E; Januszkiewicz-Lewandowska D; Czerwinska E; Ludwikowska K; Szenborn L; Gowin E; Okarska-Napierała M; Kuchar E; Ksia Zyk J
    Front Pediatr; 2022; 10():981711. PubMed ID: 36186637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.